MedTrace Logo

Multicenter Diagnostic Clinical Performance Study For Automated Detection of Diabetic Retinopathy

NCT05471986 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2023-11-29

No results posted yet for this study

Summary

This study is a retrospective study to assess the efficacy and accuracy of the EyeCheckup software in screening for diabetic retinopathy in healthcare settings.

Conditions

Interventions

DEVICE

Color Fundus Photography/Non-Mydriatic Opthalmic Cameras

Subjects will have underwent Fundus Photography using FDA approved non-mydriatic fundus cameras compatible with EyeCheckup which are either TOPCON NW400, CANNON CR2, CANNON CR2 Plus or OPTOMED AURORA IQ

Sponsors & Collaborators

  • Ural Telekomunikasyon Sanayi Ticaret Anonim Sirketi

    lead INDUSTRY

Principal Investigators

  • Rim Khazhin · Ural Telekom

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2024-12-01
Completion
2024-12-01
FDA Device
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05471986 on ClinicalTrials.gov